Parvovirus B19 is an easily transmitted virus that is common in young children but can infect gravid women if they do not have immunity. If this virus crosses the placenta and becomes a fetal infection, it can be potentially fatal to the fetus. This case report depicts the diagnosis and subsequent treatment of a fetus infected with parvovirus B19.
Parvovirus B19 is a common virus in young children that can infect nonimmune gravid women and cross the placenta to become a fetal infection. When a fetus has become infected with parvovirus B19, the pregnancy should be closely monitored to watch for the development of fetal hydrops or diminished signs of fetal well-being. Depending on the severity of the infection, invasive treatment may be required. This case depicts the diagnosis and eventual resolution of the sonographic findings of a fetal parvovirus B19 infection.
Case Report
A woman in her early 30s, gravida 4, para 1, was referred to our site at 21 weeks 4 days gestation for an abnormal sonogram where fetal ascites was noted. The sonogram confirmed that gestational age at 11 weeks 4 days was consistent with last menstrual period dating, and no abnormalities were seen during the scan. The patient received a quad screen in the second trimester that came back as low risk for trisomy 21, trisomy 18, and open neural tube defects. A routine second-trimester sonogram was performed at 21 weeks 3 days, and the only abnormality noted was fetal ascites (Figure 1) .
A targeted sonographic examination was requested at our site as a result of the fetal ascites documented at the outside site. Our level 2 scan did not reveal any anatomic abnormalities and the fetal ascites were identified. The middle cerebral artery (MCA) Doppler was obtained at 50 cm/s, with 27.9 cm/s considered the upper limit of normal at the 22-week gestational age. 1 An amniocentesis was performed and sent out to be analyzed for aneuploidy, karyotype, parvovirus, cytomegalovirus (CMV), and alphafetoprotein. Maternal blood was also drawn at this visit to be analyzed for immunoglobulin G (IgG) and immunoglobulin M (IgM) levels for parvovirus B19.
As a result of the elevated MCA Doppler and fetal ascites, the patient was scheduled for multiple sonograms to monitor fetal well-being. The patient returned 3 days after the initial visit to be scanned. At the appointment at 22 weeks 0 days, two of the lab results had been completed and returned to the office. The preliminary interphase fluorescent in situ hybridization results revealed two probe signals from chromosomes 13, 18, and 21 as well as a single signal for X and Y. The maternal blood work reported a parvovirus B19 infection with elevation of both the IgG and IgM antibodies. Sonographically, the heart appeared increased in size with moderate pericardial fluid ( Figure 2 ). Ascites was noted again as well as soft tissue edema of the scalp and chest. There was decreased movement of the fetus, and the MCA velocity was documented at 55 cm/s. An intrauterine transfusion (IUT) and percutaneous blood sampling (PUBS) were scheduled for the following day. The estimated fetal weight from the appointment three days prior was used to determine how much blood 389046J DM27110.1177/8756479310389046Reed and SundbergJournal of Diagnostic Medical Sonography 1 Olympia, WA, USA would be transfused to the fetus during the procedure. The patient was placed into an anesthesia-induced twilight state, and general anesthetic was applied to the abdomen where the needle insertion would be. Through sonographic guidance, the placental cord insertion was identified and the needle guided into the base of the umbilical vein ( Figure 3 ). The opening hematocrit of the fetus was 8%. Red blood cells were transfused into the fetus while heart rate and fetal activity were being monitored sonographically. The closing fetal hematocrit was just under 34%. At 22 weeks 4 days, 3 days posttransfusion, a sonogram was performed that noted a heart that appeared subjectively enlarged but taking up less than 50% of the thoracic cross section, pericardial fluid, and ascites. Soft tissue edema of the scalp and chest were again noted, and the MCA Doppler was 48 cm/s. When the fetus reached 23 weeks 0 days, the MCA Doppler had decreased to 47 cm/s. Although the pericardial effusion and ascites were both present, the scalp edema had appeared to decrease. At this time, the polymerase chain reaction (PCR) run on the amniotic fluid had come back positive for parvovirus B19. At 23 weeks 3 days, the MCA Doppler was 45 cm/s. The pericardial effusion and ascites had not changed in apparent severity from the sonogram 3 days prior, but there was no visible edema of the scalp or chest.
At 24 weeks 0 days, the scan also included fetal anatomy and biometry. The interval growth of the fetus was consistent with gestational age everywhere except the abdomen, which was increased in size as a result of the ascites. The fetal anatomy continued to appear appropriate for gestational age. A pericardial effusion was noted along with persistent ascites and a subjectively enlarged heart size still taking up less than 50% of the thoracic cross section. The MCA Doppler had decreased to 33 cm/s. The following day, the final chromosome analysis revealed a normal male karyotype (46, XY), and the qualitative CMV test came back negative.
At a gestational age of 24 weeks 3 days, the ascites began to resolve, and only a small pericardial effusion was noted. The MCA Doppler was recorded at 32 cm/s. The patient returned again at 25 weeks 0 days with a sonographic finding very similar to those at the last examination. A small pericardial effusion was present with moderate ascites and an MCA Doppler of 34 cm/s. As a result of the decreased MCA velocity, the patient was able to schedule the next examination for 7 days out. The sonogram at 26 weeks 0 days showed no evidence of fetal hydrops. The MCA velocity was 35 cm/s, but polyhydramnios was noted with an amniotic fluid index of 20.2 cm, with 18.7 cm being the 95th percentile for this gestational age. 2 Because the fetal hydrops had resolved and the MCA Doppler had decreased, the patient was scheduled for a follow-up sonogram in 4 weeks. The examination at 30 weeks 0 days showed no evidence of fetal hydrops present. The fetal liver did appear subjectively enlarged, and the abdominal circumference was measuring 1 week 6 days greater than expected. All other fetal anatomy appeared consistent with gestational age. The fetus received an 8/8 for the biophysical profile, and the amniotic fluid index was back within normal limits at 14.0 cm. 2
Discussion
Parvovirus B19 is a DNA virus of the Parvoviridae family. [3] [4] [5] This single-stranded nonenveloped virus is the only strain of parvovirus that is known to infect humans, as parvoviruses tend to be specific to a particular species. 4, 5 This easily transmittable virus has been recognized since 1984 as a cause for fetal anemia and hydrops in cases where the fetus has been infected. [4] [5] [6] This virus spreads so easily because it is very common in young or school-aged children and is passed through close personal contact, respiratory secretions, and blood. 4, 5, 7 Once a person has been exposed to this virus, he or she develops immunity, and as a result of parvovirus B19 being so common in young children, only 20% of infections occur in adults. 7 At the onset of pregnancy, 50% to 65% of pregnant women are immune. 4 The most common way that pregnant women contract this virus is through close contact with their own children. 3, 4, 7, 8 There is also an elevated risk for pregnant women in professions such as schoolteachers and daycare providers who have prolonged exposure to young children. 5, 7 Children will be asymptomatic 25% of the time and adults 75% of the time when they are infected with parvovirus B19. 4, 7 Therefore it is possible for a pregnant woman to be unaware of exposure to the parvovirus. Only 21% of pregnant women exposed to parvovirus pick up the virus, but in 50% of maternal parvovirus infections, the virus is asymptomatic. 3, 5 In pregnancy, parvovirus B19 is a concern because of its ability to be transmitted transplacentally. 4, 5 In maternal parvovirus infections, the virus will cross the placenta and infect the fetus 30% to 33% of the time. 4, 5, 7 A fetus infected with parvovirus B19 will have a 7% chance of developing nonimmune hydrops and a 2% to 10% risk of fetal loss. 3, 7 Parvovirus B19 is cytotoxic for erythroid progenitor cells and can lead to fetal anemia by inhibiting erythropoiesis. 5, 7 This leads to a decrease in hemoglobin reaching the brain, and as a result, the heart increases its stroke volume to compensate, leading to nonimmmune hydrops. 8, 9 Nonimmune fetal hydrops occurs in 1 out of 3000 to 4000 pregnancies. 5 Parvovirus causes 10% of nonimmune hydrops cases, and hydrops will only develop in 1% to 3% of pregnancies where parvovirus is present. 4, 5, 7 Twelve weeks after maternal infection, fetal complications will typically present. 7 Sonography is the modality of choice to detect hydrops, and two or more of the following findings must be present: edema of the fetal skin or scalp, fetal ascites, pericardial effusion, or pleural effusion. 7, 10, 11 Additional findings associated with fetal hydrops may include polyhydramnios, an edematous placenta, hepatosplenomegaly, and cardiomegaly. 7 Sixty to seventy percent of nonimmune hydrops cases are a result of chromosomal abnormalities, cardiovascular defects, thoracic problems, twin-to-twin transfusion, infection, or anemia. 10 In certain circumstances, sonography may be able to identify the cause of the hydrops, but otherwise, it is used in conjunction with invasive testing in an attempt to identify the source. Maternal blood work, amniocentesis, and percutaneous umbilical blood sampling are some of the methods used to look for the cause of the hydrops. 10 There are different methods of confirming a parvovirus infection in pregnancy. By testing maternal blood, parvovirus can be detected through looking at IgG and IgM. 8 Elevation of both IgG and IgM shows recent maternal exposure to parvovirus B19. 4 IgM antibodies will be elevated 21 to 24 days after exposure, whereas IgG antibodies are elevated 24 to 28 days after exposure and will maintain an elevated level. 4 This IgG elevation indicates immunity to future parvovirus infections. 4 This test is obviously time sensitive, and drawing maternal blood too early after initial exposure may show whether the gravid woman is immune but may not reveal the viral infection. 8 When fetal hydrops is found, PCR for parvovirus B19 DNA is a highly sensitive way to detect a parvovirus infection and can be used with maternal serum or amniotic fluid. 4, 8 A pitfall of this method is that samples can be easily contaminated and become inconclusive, so samples must be collected correctly. 8 Maternal serum or amniotic fluid alpha-fetoprotein levels may be elevated in fetal parvovirus infections. 4 This may be a result of damage to fetal liver cells or infection of placental cells, but an elevated alpha-fetoprotein level is not considered an indicator for parvovirus infection. 4 When a maternal parvovirus infection has been confirmed and fetal hydrops is observed, the hydrops is likely a result of fetal parvovirus infection and resulting anemia. The only way to diagnose fetal anemia is by obtaining a hematocrit through a cordocentesis or percutaneous umbilical blood sampling. 9 This invasive diagnostic tool carries with it the risk of infection, bleeding, and fetal demise. 6 A noninvasive method of monitoring a fetus at risk of developing anemia is by obtaining a waveform Doppler of the MCA. 6, 9, 12 When a fetus begins to develop anemia, less oxygen is being carried through the body and to the brain. As a result, the fetal heart increases stroke volume in an attempt to make up for the oxygen shortage. The increased stroke volume leads to an increased velocity in all arterial vessels in the fetus. 6, 12 Doppler of the MCA was chosen because it is typically not necessary to use angle correct, and the image is easy to reproduce. 6 The fetus should be relatively still when this measurement is obtained because in an active state, the peak systolic velocity (PSV) in the MCA can elevate as a result of increased fetal heart rate. 6, 12 With Doppler of the MCA, an axial image of the head should be obtained at the level of the thalamus and the cavum septi pellucidi. 12 With utilization of color Doppler, the circle of Willis should be visible, and the MCA will come up directly toward the transducer if the fetal head is in the true axial plane. 6, 12 The Doppler gate should be placed close to the circle of Willis with care not to slide into its origin from the internal cerebral artery (ICA) or the anterior cerebral artery that is also branching from the ICA. 6, 9 If the MCA is coming directly toward the transducer, no angle correct is necessary to obtain the PSV in the MCA. If the MCA is coming directly toward the transducer, no angle correct is necessary to obtain the PSV in the MCA. However, angle correct should be used if the fetal head is positioned so the MCA is coursing at an angle. 12 With each gestational age, there is an appropriate range for the PSV of the fetal MCA to fall under (Figure 4 ). 9 As a fetus continues to progress through gestation, the MCA PSV will increase. 9 With sonographic monitoring, it becomes a concern, or a red flag for fetal anemia, if the PSV of the MCA suddenly undergoes a dramatic increase within a short period. 9 A study by Chiaie et al. 6 in 2001 revealed a sensitivity and specificity of 100% between an increased PSV in the MCA and fetal anemia as a result of a parvovirus B19 infection.
Conclusion
This case report shows the sonographic characteristics of hydrops fetalis in a case of confirmed fetal parvovirus B19 infection. In this case, sonography was used to monitor fetal well-being and progression of hydrops fetalis as well as monitoring MCA velocities and guiding for the invasive PUBS and IUT procedures. The fetus needs to be closely monitored because drastic changes in MCA velocities and severity of hydrops can occur in a short period. Parvovirus B19 can be a serious and fatal infection in fetuses if not monitored and treated appropriately.
